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The mechanism by which sphingosine-1-phosphate
receptor-1 (S1P1) acts to promote lymphocyte egress
from lymphoid organs is not defined. Here, we
showed that CCR7-deficient T cells left lymph nodes
more rapidly thanwild-type cells did, whereas CCR7-
overexpressing cells were retained for longer. After
treatmentwith FTY720, an agonist that causes down-
modulation of lymphocyte S1P1, CCR7-deficient
T cells were less effectively retained than wild-type
T cells. Moreover, treatment with pertussis toxin to
inactivate signaling via Gai-protein-coupled recep-
tors restored egress competence to S1P1-deficient
lymphocytes. We also found that T cell accumulation
in lymph node cortical sinusoids required intrinsic
S1P1 expression and was antagonized by CCR7.
These findings suggest a model where S1P1 acts in
the lymphocyte to promote lymph node egress by
overcoming retention signals mediated by CCR7
and additional Gai-coupled receptors. Furthermore,
by simultaneously upregulating S1P1 and downregu-
lating CCR7, T cells that have divided multiple times
switch to a state favoring egress over retention.
INTRODUCTION
Lymphocyte egress from lymphoid organs is essential for im-
munsurveillance and for lymphocyte effector function. After entry
into lymphoid tissues, lymphocytes spend several hours to a day
migrating extensively within the tissue prior to exiting and return-
ing to circulation (Cyster, 2005). Lymphocyte entry into lymph
nodes occurs via high endothelial venules (HEVs) and requires
the concerted action of selectins, chemokines, and integrins
(von Andrian and Mempel, 2003). The principal chemokine
receptor involved in entry, CCR7, is highly expressed on T cells,
and the ligand, CCL21, is abundant on HEV and is present on
stromal cells throughout the T zone. The second CCR7 ligand,
CCL19, is also expressed by T zone stromal cells (Cyster,
2005). Recent work has shown that CCR7 and CCR7 ligands122 Immunity 28, 122–133, January 2008 ª2008 Elsevier Inc.not only are involved in cell entry to lymphoid tissues but also
promote T cell motility within the T zone (Huang et al., 2007;
Okada and Cyster, 2007; Worbs et al., 2007).
In contrast to the established cascade of molecular interac-
tions required for cell entry from blood into tissues, the multistep
requirements for egress have not been well defined. Egress
occurs from lymph nodes and Peyer’s patches into efferent lym-
phatics and from spleen into blood (Cyster, 2005). The exact site
of egress in each of these tissues is not firmly established,
although egress from lymph nodes is typically thought to occur
at the medullary sinuses that connect to the subcapsular space
and the efferent lymphatic (Sanna et al., 2006; Wei et al., 2005).
An additional sinus structure that begins in the T zone and joins
with the medullary sinuses, termed the cortical sinusoid, was
also suggested on the basis of ultrastructural studies to be
involved in egress (Kelly, 1975; Soderstrom and Stenstrom,
1969). However, the role of cortical sinusoids in egress has not
been further explored.
Important insight into molecular requirements for lymphocyte
egress came from the finding that the immunosuppressant
molecule, FTY720, inhibited egress (reviewed in Cyster [2005];
Rosen et al. [2007]). After in vivo treatment, FTY720 becomes
phosphorylated and the phosphoform is an agonist on four of
the five sphingosine-1-phosphate (S1P) receptors including
S1P receptor-1 (S1P1), a receptor that signals via Gai-containing
heterotrimeric G proteins (Rosen et al., 2007). Genetic studies
have established that S1P1 is needed in the lymphocyte for
normal egress to occur from thymus and peripheral lymphoid
tissues (Allende et al., 2004; Matloubian et al., 2004). Recent
work has shown that S1P is required for induction of egress
(Pappu et al., 2007) and treatments that cause elevations in
lymphoid tissue S1P abundance disrupt egress (Schwab et al.,
2005). Despite these advances, the mechanism by which S1P1
acts in the lymphocyte to promote egress has been unclear.
In earlier work, we suggested that FTY720 acts to inhibit
egress by downregulating and functionally antagonizing lympho-
cyte S1P1 (Matloubian et al., 2004). However, engagement of
endothelial S1P1 can increase tight-junction formation, and it
has been proposed that FTY720 may instead inhibit egress by
closing egress portals (Sanna et al., 2006; Wei et al., 2005).
Thus, the mechanism by which FTY720 and other S1P1 agonists
inhibit lymphocyte egress is still debated (Rosen et al., 2007).
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lymphocyte S1P1 promotes egress: (1) It functions to overcome
signals that retain cells in the lymphoid tissue; (2) it transmits
unique signals that promote migration or transmigration into
exit structures. Here, we have performed experiments that test
the first of these models. We demonstrate that CCR7 and addi-
tional Gai-coupled systems promoted T cell retention within lym-
phoid organs and that lymphocyte S1P1 functioned to overcome
these retention signals. Inhibition of lymphocyte Gai allowed
egress of cells in FTY720-treated hosts, providing further evi-
dence that this drug inhibits egress by acting on the lymphocyte.
Lymph node cortical sinusoids were identified as a site where
S1P1 acted during lymphocyte egress from lymph nodes. To-
gether, these studies provide evidence for a model where S1P1
functions to promote egress at least in part by overcoming
signals that retain cells in the lymph node.
RESULTS
CCR7 Promotes T Cell Retention in Lymph Nodes
To test whether CCR7 can mediate T cell retention in lymph
nodes, we cotransferred CCR7-deficient and wild-type spleno-
cytes into wild-type recipient mice and allowed the cells to equil-
ibrate for 1 day. To inhibit further entry of circulating lymphocytes
into lymph nodes, we treated the mice with integrin-neutralizing
antibodies (‘‘entry blockade’’), and cotransferred cells were enu-
merated either at the treatment time (t = 0 hr) or 8 hr later (t = 8 hr).
Previous studies have shown that aL- and a4-containing integ-
rins are not required for lymphocyte egress (Arnold et al., 2004;
Lo et al., 2005) and treatment with these antibodies achieves
a more complete blockade of entry into mucosal lymph nodes
than is achieved by loss of CD62L function (Arbones et al.,
1994; Berlin-Rufenach et al., 1999). CCR7 deficiency resulted
in more rapid exit of T cells from mesenteric and peripheral
lymph nodes relative to the cotransferred control T cells
(Figure 1A). B cell exit efficiencies were not affected by CCR7
deficiency (Figure S1 available online). As another approach to
examine the exit efficiency of CCR7-deficient cells, we gener-
atedmixed bone-marrow chimeras andmeasured the frequency
of wild-type and CCR7-deficient cells in lymph versus lymph
nodes. In mice reconstituted with a mixture of wild-type
CD45.1 and wild-type CD45.2 cells, the frequency of the two
types of cells in lymph nodes and in lymph were similar (Fig-
ure 1B). In contrast, in mice reconstituted with a mixture of
wild-type CD45.1 cells and Ccr7/ CD45.2 cells, there was an
enrichment of Ccr7/ cells in lymph compared to lymph nodes
(Figure 1B). The frequency of CD45.1 and CD45.2 B cells in
lymph and lymph nodes was similar for both groups (Figure S1).
These observations suggest that CCR7-deficient T cells exit into
lymph more rapidly than wild-type T cells.
Analysis of Ccr7/ T cell distribution in lymph node sections
revealed that the cells were mostly located near HEV and areas
positive for the lymphatic marker LYVE-1, and they were not
distributed in the deeper T zone (Figure 1H) as expected (Fo¨rster
et al., 1999). Interestingly, the mean S1P1 surface expression
was lower on CCR7-deficient T cells than on control T cells
present in the same lymph nodes, although some of the CCR7-
deficient cells did express normal amounts of the receptor
(Figure 1C). It seemed likely that the lower expression reflectedincreased exposure of the mispositioned cells to S1P because
lymphocyte S1P1 is highly sensitive to downmodulation by S1P
(Lo et al., 2005; Schwab et al., 2005).
In an attempt to distinguish whether CCR7-deficiency led to
more rapid egress because the T cells were more poised to
respond to exit-promoting signals or because of their inability
to distribute through the T zone and away from possible exit
sites, we performed two further types of experiments. First, we
asked whether Ccr7+/ T cells showed evidence of more rapid
egress. Flow cytometric analysis confirmed that Ccr7+/ T cells
have about half the normal amount of CCR7 (Figure 1D). With
the adoptive transfer followed by entry-blockade procedure,
Ccr7+/ cells showed a trend toward more rapid egress com-
pared to cotransferred wild-type control cells at 8 hr (not shown)
and a significant difference after 14 hr (Figure 1E). Flow cytomet-
ric analysis of lymph and lymph node cells from recipient mice
that had not been antibody treated showed a greater frequency
of Ccr7+/ cells in lymph compared to lymph nodes (Figure 1F).
However, in contrast to the Ccr7/ cells, Ccr7+/ cells were
distributed throughout the lymph node T zone (Figure 1H), and
they had normal amounts of surface S1P1 (Figure 1C).
In the second type of experiment, we asked whether overex-
pression of CCR7 could lead to increased retention of cells
in lymph nodes. Circulating peripheral T cells from transgenic
mice overexpressing CCR7 under the control of a CD4 minigene
(Kwan and Killeen, 2004) have 2-fold more CCR7 on their
surface (Figure 1D). Transgenic T cells were cotransferred with
control T cells into wild-type mice and equilibrated for 1 day,
and further cell entry into lymph nodes was inhibited by integ-
rin-neutralizing antibodies. Cotransferred cells were enumerated
at the time of entry blockade (t = 0 hr) and 12 hr later (t = 12 hr). A
greater fraction of the CCR7-transgenic T cells were retained in
mesenteric and peripheral lymph nodes compared to cotrans-
ferred control cells over the 12 hr (Figure 1G). In contrast to
CCR7-deficient T cells, the transgenic T cells were distributed
throughout the T zone (Figure 1H) and they exhibited normal
surface S1P1 levels (Figure 1C). Taken together, these results
indicate that CCR7 promotes T cell retention in lymph nodes,
and they suggest the involvement of mechanisms other than
regulation of gross distribution within the T zone.
CCR7 Deficiency Promotes T Cell Egress
in FTY720-Treated Hosts
To examine the possibility that S1P1 acts to promote lymphocyte
egress by overcoming lymphoid-tissue retention signals, we set
out to test whether CCR7 deficiency reduced the dependence of
T cells on S1P1 for undergoing egress. As a component of these
studies, we further examined the relationship between FTY720
treatment and modulation of lymphocyte S1P1 function. We
treated mice for the same short (4–5 hr) time period and with
doses corresponding to the range previously used to define
the IC50 for egress inhibition by the active FTY720 enantiomer
(Rosen et al., 2003). Comparison of the effect of FTY720 on
T cell S1P1 surface expression and on cell numbers in lymph
and blood showed that there was a strong positive correlation
(Figures 2A and 2B). Notably, FTY720 at 0.05 mg/kg caused
approximately 50% S1P1 downmodulation, achieving amounts
similar to those in cells with heterozygous deficiency in Edg1,
the gene encoding S1P1 (Figure 2C), and the treatment led to
Immunity 28, 122–133, January 2008 ª2008 Elsevier Inc. 123
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S1P1 Overrides Retention Signals to Promote EgressFigure 1. CCR7 Affects T Cell Egress Rates from Lymph Nodes
(A) Wild-type and Ccr7/ spleen cells were cotransferred to wild-type recipients, and after 24 hr, the mice were treated with integrin-blocking antibodies for 8 hr.
The data shown indicate the fraction of T cells remaining in recipient mesenteric (m) and peripheral (p) lymph nodes at 8 hr compared to 0 hr.
(B) Irradiated mice were reconstituted with mixtures of CD45.2+ Ccr7+/+ or Ccr7/ bone marrow and CD45.1+ WT bone marrow, and the representation of
CD45.2+ cells in peripheral and mesenteric lymph nodes (LN) and in lymph (LYM) was determined.
(C) Flow cytometric analysis of S1P1 on Ccr7
/ and Ccr7+/+ CD4 T cells from lymph nodes of mixed bone-marrow chimeras (left panel) and Ccr7+/ (middle
panel) or Ccr7-Tg (right panel) CD4+ T cells together with cotransferred control cells. Shaded histograms show staining with control antibody.
(D) Flow cytometric data showing CCR7 expression with anti-CCR7 mAb on Ccr7+/ and littermate control (upper panel) or Ccr7-Tg and littermate control (lower
panel) lymph node CD4+ T cells. Shaded histograms show staining of Ccr7/ cells.
(E and F) Transfers and integrin blockadewere performed as in (A). In (E), the fraction of cells remaining after 14 hr in the indicated lymph nodeswas determined. (F)
shows the ratio of transferred Ccr7+/ and Ccr7+/+ T cells in peripheral and mesenteric lymph nodes (LN) and in lymph (LYM) at 0 hr.
(G) Wild-type control andCcr7-Tg cells were transferred to wild-type recipients, and themice were treated as in (A). The data shown indicate the fraction of T cells
remaining in the indicated lymph nodes at 12 hr compared to 0 hr of entry blockade.
In (A) and (B) and (E)–(G), bars indicate mean and points indicate data from individual mice.
(H) Distribution of WT, Ccr7/, Ccr7+/, and Ccr7-Tg cells within peripheral lymph nodes. CFSE-labeled T cells were transferred into wild-type recipients, and
1 day later lymph node sections were stained to detect transferred cells (blue) and LYVE-1+ sinusoids (brown). Objective magnification, 53.a similar decrease in T cell numbers in lymph and blood to the
reductions observed in Edg1+/mice (Figures 2B and 2D). These
findings provide support for the conclusion that FTY720-induced
downmodulation of lymphocyte S1P1 contributes to the mecha-
nism by which this drug reduces lymphocyte egress.
124 Immunity 28, 122–133, January 2008 ª2008 Elsevier Inc.To test whether S1P1 functioned in part to overcome CCR7-
mediated retention, we reconstituted wild-type mice with a mix-
ture of wild-type and CCR7-deficient bone-marrow cells and
then treated the mice with FTY720 to modulate S1P1 function.
The mice were also treated with integrin-blocking antibodies to
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S1P1 Overrides Retention Signals to Promote EgressFigure 2. Dose Sensitivity of FTY720-Mediated S1P1 Modulation and Induction of Lymphopenia
(A) FACS analysis of S1P1 on lymph node CD4
+ T cells 4.5 hr after in vivo treatment with the indicated amounts of FTY720.
(B) Fraction of CD4+ T cells remaining in blood (BLD) and lymph (LYM) 4.5 hr after treatment with the indicated amounts of FTY720 compared to saline-treated
controls.
(C) FACS analysis of S1P1 on wild-type littermate control and Edg1
+/ lymph node CD4+ T cells.
(D) Number of CD4+ T cells in blood and lymph of wild-type and Edg1+/mice. Data are representative of at least three mice for each condition. Bars represent
means and dots individual mice.ensure that any differences observedwere not due to differences
in lymph node entry. As expected, FTY720 strongly inhibited
lymph node egress, and reduced numbers of cells were present
in lymph after 1 day of combined FTY720 treatment and entry
blockade (Figure 3A). However, among the T cells continuing
to appear in lymph at this time, there was a strong increase in
the representation of CCR7-deficient cells (Figures 3A and 3B).
In contrast, there was no change in the proportion of CCR7-de-
ficient B cells appearing in the lymph (Figure 3A). To correct for
differences in the extent of reconstitution by the CD45.1 and
CD45.2 bone-marrow cells in individual animals, we normalized
the frequency of each T cell type in the lymph by that in the lymph
nodes of the same animals, and this confirmed that there was
a significant overrepresentation of CCR7-deficient cells in lymph
of FTY720-treated animals (Figure 3C). Thus, although total
numbers of T cells were reduced in the lymph of all the animals
after FTY720 treatment, the CCR7-deficient cells were reduced
by only 60%–70% versus more than 90% for wild-type cells.
The treatments did not cause detectable changes in lymphnode T cell numbers over the period of these experiments. Taken
together, these findings support a model where S1P1 functions
within T cells in part to overcome CCR7-mediated retention.
Pertussis-Toxin Treatment Promotes Egress
of S1P1-Deficient Cells
Although reproducible, CCR7 deficiency led to only a partial
recovery in T cell egress into lymph of FTY720-treated mice.
We next asked whether additional Gai-coupled receptors were
involved in retention by using a pertussis toxin (PTX) pulse-load-
ing procedure that allows cell entry into lymph nodes during the
first 2–3 hr after transfer, prior to Gai inactivation by the PTX en-
zyme (Lo et al., 2005; Okada andCyster, 2007) (see Experimental
Procedures). Cells pulse loaded with PTX or the nonenzymatic
(oligomer B) subunit as control were cotransferred into saline-
or FTY720-treated recipients, and after 3 hr further entry of cells
into lymph nodes was blocked by treatment with integrin-neu-
tralizing antibodies. Cell numbers were measured at 0 and 21 hr
after integrin blockade. Using this approach, we found that
Immunity 28, 122–133, January 2008 ª2008 Elsevier Inc. 125
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S1P1 Overrides Retention Signals to Promote EgressFigure 3. FTY720-Mediated Inhibition of T Cell Egress Is Partially CCR7 Dependent
(A) Flow cytometric analysis of CD45.2+ Ccr7/ and CD45.1+ WT T and B cells in mixed bone-marrow chimeras treated for 24 hr with saline or FTY720 and with
integrin-blocking antibodies for 20 hr. Numbers indicate percent cells in the indicated gates out of total T or B cells. The means (± standard deviation [SD]) of
lymphocyte numbers in the samples were as follows: saline lymph = 6.3 3 103/ml (± 4.5 3 103), n = 8; FTY720 lymph = 7.5 3 102/ml (± 9.7 3 102), n = 9; saline
LN = 1.3 3 107 (± 4.0 3 106), n = 8; FTY720 LN = 1.6 3 107 (± 8.1 3 106), n = 9.
(B) Frequency of CD45.2+ T cells in the peripheral LN, mesenteric LN, and lymph of mice that had been reconstituted as in (A) (Ccr7/ mixed chimera) or with
a mixture of CD45.2+ Ccr7+/+ and CD45.1+ WT bone marrow as a further control (Ccr7+/+ mixed chimera).
(C) Same data as in (B), plotted as the ratio of T cell frequencies in lymph versus peripheral lymph nodes for each animal.
Bars in (B) and (C) represent mean and points represent individual animals, and the data are pooled from three experiments.Gali inactivation facilitated release of T cells (Figure 4A) and
B cells (Figure S1) from lymph nodes of FTY720-treated mice.
When compared to saline-treated hosts, a similar fraction of cells
was released, suggesting that amajor effect of FTY720 had been
overcome by lymphocyte PTX treatment (Figure 4A). The low
numbers of cells that seed recipient lymphoid tissues in this
adoptive-transfer approach made lymph measurements diffi-
cult, but among the small number of cells in lymph of FTY720-
treated animals, there was a strong bias in favor of PTX-treated
cells (Figure S2). Analysis of blood samples showed that greater
numbers of transferred PTX-treated than control-treated cells
were present at 0 hr, perhaps because of inefficient entry into
tissues (Figure 4A). At 21 hr, the number of PTX-treated cells in
the blood of saline- and FTY720-treated recipients was compa-
rable, consistent with similar extents of egress (Figure 4A).
We then asked whether Gai inhibition would restore egress
competence to T cells that lacked S1P1 expression. T cells
126 Immunity 28, 122–133, January 2008 ª2008 Elsevier Inc.from the thymus of S1P1-deficient fetal liver chimeras were
pulsed with PTX or oligomer B and then transferred to wild-
type mice (Figure 4B). After allowing 3 hr for cell entry into lymph
nodes, we blocked further entry by integrin neutralization. One
day later, we found that a significant fraction of the PTX-treated
but not of the oligomer B-treated T cells had been released from
the lymph nodes, and increased numbers of cells were detected
in blood (Figure 4C). These observations suggest that when Gai
signaling is inhibited, S1P1 in T cells is not essential for egress
from lymph nodes, and they support the idea that S1P1 promotes
egress at least in part by counteracting retention signals medi-
ated by Gai-coupled receptors including CCR7.
LYVE-1+ Cortical Sinusoids and Lymphocyte Exit
For a direct interplay to occur between S1P1 and CCR7 during
egress, we speculated that both signals needed to be encoun-
tered in a common microenvironment. Although T cell egress
Immunity
S1P1 Overrides Retention Signals to Promote EgressFigure 4. PTX Treatment Facilitates Egress of FTY720-Exposed and S1P1-Deficient Cells
(A) Egress of PTX- or oligomer B-treated T cells from lymph nodes of FTY720-treated mice. Splenocytes were treated with PTX or with oligomer B (Oligo-B) as
a control and cotransferred into hosts pretreated with saline or FTY720 4 hr earlier. Three hours after transfer, the mice were treated with integrin-blocking an-
tibodies. The number of remaining cells in lymph nodes 21 hr after ‘‘entry blockade’’ was determined. Numbers shown are normalized for the number of input
splenocytes.
(B and C) PTX restores egress of S1P1-deficient lymphocytes. (B) Diagram of transfer experiment. (C) Number of transferred oligomer B- or PTX-treated Edg1
/
or Edg1+/+ T cells in peripheral lymph nodes and blood at 0 hr and 27 hr of integrin blockade. Numbers shown are normalized for the number of CD62L-high,
single-positive input thymocytes. Bars represent mean and points represent individual animals.from lymph nodes is usually considered to occur at themedullary
sinuses, areas where CCR7 ligand abundance is low, ultrastruc-
tural studies have suggested that ‘‘upstream’’ cortical sinusoids
may also be involved (Kelly, 1975; Soderstrom and Stenstrom,1969). Staining of lymph node sections for the lymphatic marker
LYVE-1 (Jackson et al., 2001) revealed numerous positive cells in
the macrophage-rich medullary region, as expected, and also
identified LYVE-1+ sinusoids in the T zone or paracortex, oftenImmunity 28, 122–133, January 2008 ª2008 Elsevier Inc. 127
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S1P1 Overrides Retention Signals to Promote EgressFigure 5. S1P1-Deficient Cells Are Found Less Frequently within Cortical Sinusoids
(A) Serial sections of lymph node stained for LYVE-1 (brown) and IgD (blue) or CD11b (blue) showing LYVE-1-expressing structures extending from cortical areas
into the macrophage-rich medullary region.
(B) Proximity of cortical LYVE-1+ structures (blue) to PNAd-expressing HEV (brown).
(C) LYVE-1+ cortical structures (brown) contain B cells (IgD, blue) and T cells (CD3, blue) but are relatively devoid of dendritic cells (CD11c, blue).
(D) CCL21 expression (blue) in wild-type lymph nodes with respect to LYVE-1 (brown).
(E) Effect of S1P1-deficiency on T cell appearance in cortical sinusoids. CD45.2
+ thymocytes from wild-type or S1P1-deficient fetal liver chimeras were labeled
with CFSE, and each population was cotransferred with wild-type (CD45.1+) thymocytes into B6 (CD45.2+) mice. Thirty-six hours after transfer, recipient lymph
nodes were sectioned and stained to detect the fetal-liver-chimera-derived (CSFE+) T cells (blue) and the cotransferred wild-type cells (CD45.1, red) and for
LYVE-1 (E).128 Immunity 28, 122–133, January 2008 ª2008 Elsevier Inc.
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5A and 5B). LYVE-1 staining of sinusoids in the paracortical
region has recently been reported (Hirakawa et al., 2005; Prevo
et al., 2004). In some lymph node cross-sections, LYVE-1+ sinu-
soids could be observed extending from the T cell rich paracort-
ical region to medullary areas (Figure 5A). These paracortical
structures typically contained numerous T cells and B cells (Fig-
ure 5C). These combined observations lead us to categorize the
LYVE-1+ structures in the T zone as being identical to the cortical
sinusoids described in ultrastructural studies (Belisle and Sainte-
Marie, 1981; Compton and Raviola, 1985; Kelly, 1975; Kowala
and Schoefl, 1986; Soderstrom and Stenstrom, 1969). In
contrast to their rich lymphocyte content, the cortical sinusoids
contained few dendritic cells (Figure 5C). Because dendritic cells
undergo only very limited egress from lymphoid organs, their
deficiency in the cortical sinusoids is consistent with these struc-
tures playing a role in lymphocyte egress.
Cortical sinusoids were located in areas rich in the CCR7
ligand CCL21 (Figure 5D). It is currently not possible to stain
for the S1P1 ligand, S1P. We therefore sought an alternative ap-
proach to determine whether S1P1 function was required at the
level of the cortical sinusoid and tested the impact of S1P1 defi-
ciency on the appearance of transferred T cells in cortical sinu-
soids. Thymocytes from Edg1/ or Edg1+/+ fetal liver chimeras
were transferred, together with allelically marked control cells,
into wild-type recipients. One day later, few Edg1/ cells could
be detected within LYVE-1+ cortical sinusoids, whereas Edg1+/+
cells were observed in cortical sinusoids at a similar frequency as
the costransferred control T cells (Figure 5E and Figures S3A and
S3B). Enumeration of wild-type and S1P1-deficient T cells within
sinusoids and in a 30-mm-thick region surrounding each struc-
ture confirmed that S1P1-deficient cell accumulation inside sinu-
soids was strongly inhibited (Figure 5F). The ratio of S1P1-defi-
cient to wild-type cells in the immediate vicinity of the sinusoid
(0.73 ± 0.63, Figure 5F) was little different than the ratio in the
central T zone (0.65 ± 0.16, n = 13). A similar frozen-tissue anal-
ysis of T cell distribution within the medullary region could not be
performed because the high density of LYVE-1 staining did not
allow sinus and nonsinus areas to be distinguished. These find-
ings indicate that T cells require S1P1 for entry into or accumula-
tion within LYVE-1+ cortical sinusoids but that the receptor is not
critical for T cells to approach these structures.
We next asked whether CCR7 antagonized appearance of
cells within sinusoids by using Ccr7+/ cells because they enter
lymph nodes with similar efficiency to wild-type cells and distrib-
ute through the T zone (Figure 1H). Ccr7+/ T cells were found at
a higher frequency inside LYVE-1+ sinusoids than in the immedi-
ately surrounding regions (Figure 5G and Figure S3). In control
experiments, allelically distinguishable wild-type populations
were equally represented in sinusoids and in the surrounding re-
gions (Figure 5G). These observations indicate that CCR7 antag-
onizes T cell entry into or accumulation inside LYVE-1+ sinusoids,and they suggest that this effect cannot be explained solely by
influences of CCR7 on cell proximity to these structures.
To further test for a direct interplay between CCR7 and S1P1,
we tested the ability of CCL21 to retain cells against an S1P gra-
dient in transwell-migration assays. In the absence of CCL21,
naive T cells migrated to the lower chamber in response to
S1P (Figure 5H). However, when CCL21 was included with the
cells in the upper chamber at 1 mg/ml, a concentration within
the range estimated to exist in lymph node T zones (Luther
et al., 2002), wild-type T cells could no longer migrate to S1P
in the lower chamber (Figure 5H). This retention effect was fully
dependent on CCR7 expression by the T cells (Figure 5H). These
results are consistent with the possibility that there is a direct
interplay between lymphocyte CCR7 and S1P1 at the level of
entry into or retention within LYVE-1+ cortical sinusoids.
T Cells that Have Divided Multiple Times Become S1P1
hi
and Have Reduced CCR7 Function
Our findings identified an antagonistic relationship between
CCR7 and S1P1 in determining the egress of naive T cells. Acti-
vated T cells initially downregulate S1P1 transcription and are re-
tained in the responding lymph node, and by day 3 the daughter
cells begin recovering S1P1 transcripts and S1P responsiveness
(Matloubian et al., 2004). Activated T cells are also known to
downregulate CCR7 function (Ansel et al., 1999; Hardtke et al.,
2005). Here, we examined the relationship between the extent
of cell division and the reciprocal changes in S1P1 and CCR7
function following in vivo activation. We found that at day 3 of the
OTII T cell response to ovalbumin (OVA) in adjuvant, S1P1was re-
expressed on a large fraction of the T cells that had undergone
four or more divisions (Figure 6A). Chemotaxis assays showed
that recovery of S1P1 function was most prominent in cells that
had divided four or more times (Figure 6B). Reciprocally, CCR7
was downregulated in the activated cells as assessed by surface
staining (Figure 6C) and by transcript abundance (Figure 6D),
with the downmodulation being most substantial in the cells
that had divided multiple times. CCL21 chemotactic responses
were most strongly reduced in cells that had divided more than
four times (Figure 6E). These observations suggest that once an-
tigen-engaged T cells have undergone four or more divisions,
many of the cells acquire an S1P1
hi phenotype and are function-
ally CCR7 low, a combination of changes thatmost likely reduces
the propensity of the cells tomigrate farther within the T zone and
instead favors prompt egress. Consistent with this proposal,
there was an enrichment for T cells that had undergone more
than four divisions among the divided T cells in blood and lymph
compared to draining lymph node (Figure 6F).
DISCUSSION
The above findings extend the functions of CCR7 beyond
promoting cell entry, compartmentalization, and motility withinObjective magnifications: (A) 53; (B–D) 103; (E) 203.
(F and G) Enumeration of (F) Edg1+/+ and Edg1/ cells or (G) Ccr7+/+ and Ccr7+/ cells and cotransferred wild-type control T cells inside LYVE-1+ sinusoid struc-
tures (In) and in a 30-mm-thick area surrounding each sinusoid (Out). Data are plotted as ratio of wild-type, Edg1/, orCcr7+/ cells to cotransferred control cells
in each region. Each dot represents data from a single sinusoid cross-section, and bars represent the means.
(H) Transwell migration of Ccr7+/+ or Ccr7/ CD4+ T cells in response to the indicated concentrations of S1P (nM). Cells were added to the upper wells in the
absence or presence of 1 mg/ml CCL21 as indicated. Data are representative of three experiments.
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Times Upregulate S1P1 and Downregulate
CCR7
Mice receiving CFSE-labeled OTII T cells were im-
munized s.c. with OVA in CFA or left unimmunized,
and draining lymph node cells were analyzed at
day 3.
(A) Flow cytometric analysis of S1P1 versus CFSE
on OTII T cells. The line indicates the baseline de-
termined by staining cells with a control antibody.
(B) Transwell-migration assay showing relation-
ship between cell division (Div) number and recov-
ery of S1P responsiveness. OTII T cells that had
divided 0–3 times are shown by dashed lines and
4–8 times by thin solid lines, and endogenous
CD4+ T cells are shown by a thick solid line.
(C) Flow cytometric analysis of CCR7 versus CFSE
on OTII T cells.
(D) RT-QPCR analysis of CCR7 on sorted OTII T
cells that had divided the indicated number of
times based on CFSE dilution.
(E) Transwell-migration assay showing relationship
between cell-division number and reduced CCL21
responsiveness. Bars show mean ± SD (n = 4).
(F) Overlay of CFSE profile in lymph node versus
blood and lymph, showing enrichment for highly
divided cells in circulation. Data are representative
of at least three experiments.
Each cell thenmakes a choice to respond
to one or the other cue on the basis of the
dominance of the signal. Such decision
making has been observed for neutro-lymphoid organs to demonstrate that it also has a role in favoring
lymphocyte retention within these tissues. The requirement for
S1P1 in lymphocyte egress is partially relieved by removal of
CCR7 and more fully relieved by global inhibition of lymphocyte
Gai. These findings support a model, elaborated upon below,
where S1P1 promotes lymph node egress at least in part by over-
coming Gi-mediated retention signals. LYVE-1+ cortical sinu-
soids are shown to be a site of interplay between S1P1 and
CCR7 responses, with S1P1 promoting T cell accumulation in-
side sinusoids and CCR7 countering this activity. We also find
that inhibition of lymphocyte Gai allows egress of cells from
lymph nodes of FTY720-treated mice, supporting the conclusion
that a major site of FTY720 action is the lymphocyte. Coincident
S1P1 upregulation and CCR7 downregulation occur in activated
T cells that have undergone several cell divisions and might be a
mechanism to favor rapid egress of newly generated effector
cells.
This study provides new insight regarding both anatomical
and signaling aspects of T cell egress from lymph nodes. To
integrate these findings and provide a framework for further dis-
cussion, it is helpful to consider a provisional model for the early
events leading to egress. During ‘‘random migration’’ over stro-
mal cells in the T zone (Baje´noff et al., 2006), T cells are likely
to encounter LYVE-1+ egress structures. In this location they
are suggested to be exposed to overlapping distributions of
S1P and CCR7 ligand and possibly other retention factors.
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vitro (Foxman et al., 1999; Heit et al., 2002). The molecular basis
for this type of interplay remains to be fully defined but seems
likely to depend on the ability of a dominantly signaling receptor
to compete successfully for cytoskeletal elements that are
needed for achieving cell polarity and movement. Factors that
influence which signal is dominant may include the following:
the spatial orientation in which the cell encounters the two
cues; the lag in recovery of full S1P1 surface expression
following lymph node entry (Lo et al., 2005); possible partial
desensitization of CCR7 by ligand (Kohout et al., 2004); changes
in receptor abundance or function due to T cell activation status
(Ansel et al., 1999; Hardtke et al., 2005; Matloubian et al., 2004);
and changes in ligand abundance due to immune response sta-
tus of the lymph node (Mueller et al., 2007). Partial reductions in
receptor (or ligand) expression would be expected to have
strong effects on the outcome of this cellular decision making,
and the finding that S1P1 and CCR7 hemizygosity strongly influ-
ences egress efficiency is consistent with the model. The ability
of small (2–3-fold) changes in receptor abundance to cause
repositioning of cells in competing chemoattractant gradients
has been observed in other systems (Reif et al., 2002). In cases
where the CCR7 signal dominates, the cell is suggested to con-
tinue random migration in the T zone. In cases where the S1P1
signal dominates, the cell is suggested to localize within the
LYVE-1+ sinusoid. Removal of both S1P and retention-receptor
responsiveness, for example by PTX treatment, would eliminate
Immunity
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soids by the remaining ‘‘random’’ motility. The behavior of cells
within cortical sinusoids has not yet been characterized but—
as suggested long ago (Soderstrom and Stenstrom, 1969; Kelly,
1975)—there may be a general tendency for sinusoidal cells to
move toward medullary sinuses and the efferent lymph. It is rec-
ognized that some alternatives to this model are not excluded by
current findings, and it will be important in future studies to
further characterize the dynamics of S1P1-dependent events
during T cell egress by using real-time imaging procedures.
Cortical sinusoids were possibly first identified by Soderstrom
and Stenston in their description of ‘‘mud streams’’ of lympho-
cytes in the paracortical (T cell) zone; these streams had a higher
density of cells than the average parenchyma and they some-
times appeared as sinus-like structures continuous with the
medullary sinus system (Soderstrom and Stenstrom, 1969).
Further studies described paracortical sinuses near HEV and
connecting with medullary sinuses. The paracortical sinuses
were suggested to allow cells tomove from the T zone to theme-
dulla (Belisle and Sainte-Marie, 1981; Kelly, 1975). Using LYVE-1
to identify these structures, we found that accumulation of
lymphocytes within them was S1P1 dependent and that they
contained few dendritic cells, consistent with their playing
a role in lymphocyte egress. These experiments also provided
functional evidence that S1P is available within or nearby cortical
sinusoids. The cell types responsible for generating lymph S1P
have not yet been determined, although they were shown to
be radiation resistant (Pappu et al., 2007) and may correspond
to LYVE-1+ cells.
Our studies do not address the extent to which egress occurs
via cortical sinusoids versus other sites. In ultrastructural stud-
ies, cells can be observed traversing thewall of cortical sinusoids
and medullary sinuses (Compton and Raviola, 1985; Heath and
Spalding, 1987; Nicander et al., 1991). In addition, treatment
with pharmacological S1P1 agonists has been suggested to
reduce the entry of lymphocytes from the medulla into medullary
sinuses (Mandala et al., 2002; Sanna et al., 2006; Wei et al.,
2005). Moreover, our finding that transferred CCR7-deficient
cells are enriched near LYVE-1+ medullary regions and have
downmodulated S1P1 is consistent with cells encountering
S1P in this region even before exiting the tissue. Future studies
will need to address the extent to which the S1P1-dependent
egress step occurs via cortical sinusoids, medullary sinuses,
and subcapsular sinuses. In addition to locally counteracting
S1P1 responses, CCR7 may favor retention over egress by pro-
moting T cell migration and dispersal within the T zone and away
from egress sites. In this regard it should be noted that the nature
and distribution of the additional Gai-coupled receptor ligands
that are implicated by our studies as promoting T cell retention
in lymph nodes is not known. It seems possible that competition
between S1P1 and these additional retention systems occurs
in other regions of the lymph node such as the medulla.
The ability of T cells to exit lymph nodes even when their Gai
signaling is inhibited suggests that the lymph node egress struc-
tures may be unusually permissive for cell entry, and consistent
with this notion, imaging of lymph node medullary sinuses has
suggested the presence of portals that might function as egress
hotspots (Wei et al., 2005). Ultrastructural studies have sug-
gested that cortical sinusoids may also have openings (Belisleand Sainte-Marie, 1981; He, 1985; Soderstrom and Stenstrom,
1969), although this has been debated (Heath and Spalding,
1987; Nicander et al., 1991). PTX strongly inhibits egress from
the thymus, indicating that there are unique requirements for
egress from this organ, perhaps reflecting a less penetrable en-
dothelial barrier (reviewed in Cyster [2005]). Although PTX-treat-
ment substantially rescued the egress capability of S1P1-defi-
cient cells, treated cells did not egress from lymph nodes with
wild-type efficiency, as noted in a previous study (Lo et al.,
2005). Further work will be needed to determine whether the
reduction in egress of PTX-treated cells is due to their reduced
motility (Huang et al., 2007; Okada and Cyster, 2006) or whether
it indicates an additional contribution of S1P1 beyond overcom-
ing Gi-retention signals, such as helping guide cells into regions
rich in egress structures. Although we did not observe an effect
of S1P1-deficiency on T cell localization near cortical sinusoids, it
is possible that T cell migration toward these structures can be
promoted by many signals, including S1P1. Moreover, our stud-
ies have not examined S1P1-deficient T cell migration into or
within the medulla. Consistent with a possible role of this type,
treatment with S1P1 agonists altered T cell motility in themedulla
but not the T zone (Wei et al., 2005).
On the basis of the ability of FTY720 to cause marked down-
modulation and functional inhibition of S1P1 on lymphocytes,
FTY720 was suggested to inhibit lymphocyte egress by causing
functional antagonism of S1P1 (Cyster, 2005; Matloubian et al.,
2004). An alternative mechanism that has been proposed is
agonist action on stromal cells at medullary egress sites to cause
closing of egress portals (Sanna et al., 2006; Wei et al., 2005).
In our current experiments, we observe a tight relationship be-
tween the extent of S1P1 surface downmodulation induced by
FTY720 on lymph node T cells and the extent of egress inhibition
as measured by loss of cells from lymph and blood. A similar
potency of FTY720 in causing downregulation of S1P1 on human
lymphocytes was recently reported in an in vitro study (Maeda
et al., 2007). Importantly, we find close similarity in the reduction
in egress caused by S1P1 heterozygosity as caused by the dose
of FTY720 that induces a 50% decrease in lymphocyte S1P1
abundance. These findings are consistent with the conclusion
that FTY720 inhibits egress by functional antagonism of lympho-
cyte S1P1. In further agreement with this mode of action is our
finding that PTX-treated lymphocytes egress from lymph nodes
of FTY720-treated hosts.
The identification of a role for CCR7 in mediating T cell reten-
tion within lymph nodes indicates that reduced CCR7 function
can lead to decreased cell numbers in lymphoid organs through
accelerated egress as well as reduced entry. For example, the
poor ability of CCR7-deficient regulatory T cells to suppress
T cell proliferation in lymph nodes may partly reflect inefficient
retention of these cells (Schneider et al., 2007). Similarly, the
reduced CCL21 expression in lymphoid tissues following certain
viral infections (Mueller et al., 2007) might be a mechanism to
promote release of T cells into circulation. Finally, our experi-
ments suggest that the regulated egress of newly developing
effector cells is controlled not just by downmodulation and re-ex-
pression of S1P1 (Lo et al., 2005; Matloubian et al., 2004) but also
by the parallel changes in CCR7 function. Early after activation,
S1P1 transcripts and protein are markedly downregulated, con-
sistent with the initial retention of activated cells in the responding
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S1P1 Overrides Retention Signals to Promote Egresslymphoid tissue. However, after approximately four divisions,
many of the cells not only upregulate S1P1 but also lose much
of their CCR7 function, a combination of changes that may
help ensure that these newly generated effector cells do not
further scan the lymph node T zone for antigen but exit rapidly
into circulation to travel to the site of infection.
EXPERIMENTAL PROCEDURES
Mice and Adoptive Cell Transfer
CD45.2 C57BL/6 (B6) and CD45.1 B6 mice were from the National Cancer
Institutes or a colony maintained at the University of California, San Francisco.
Ccr7/mice (Fo¨rster et al., 1999) and CCR7 Tgmice (Kwan and Killeen, 2004)
were ten generations backcrossed to B6. OTII B6 mice were as described
(Barnden et al., 1998). S1P1-deficient thymocytes were generated by reconsti-
tution of irradiated B6-CD45.1 mice with Edg1/ E12.5 fetal liver cells as
described (Matloubian et al., 2004). Ccr7 wild-type and Ccr7/ mixed bone-
marrow chimeras were made as described (Reif et al., 2002) with 50:50
mixtures of wild-type CD45.1 and littermate control or Ccr7/ CD45.2 bone
marrow. In some experiments, 2 3 107 cells per ml were labeled with 3.3
mM of carboxyfluorescein diacetate succinimidyl ester (CFSE; Invitrogen/Mo-
lecular Probes) or 10 mM of 5-(and-6)-(((4-chloromethyl)benzoyl)amino) tetra-
methylrhodamine (CMTMR, Invitrogen/Molecular Probes) in RPMI1640 con-
taining 2% FCS for 20 min at 37C and then washed by spinning through
a layer of fetal calf serum. For OTII transfers, mice that received 2 3 107
CFSE-labeled spleen and lymph node cells 1 day before were immunized sub-
cutaneously (s.c.) with 200 mg OVA (Sigma) in CFA (Sigma) as previously
described (Matloubian et al., 2004). Lymph collection was performed as
described (Matloubian et al., 2004). In brief, under a stereomicroscope, lymph
was drawn from the cysterna chyli via a fine borosilicate glass microcapillary
pipette (Sutter Instrument). Cell numbers determined by flow cytometry were
divided by the volume of collected lymph to determine the concentration.
Protocols were approved by the Institutional Animal Care and Use Committee
of the University of California San Francisco.
Antibodies and Treatments
The anti-aL (clone M17/4, rat IgG2a) hybridoma was from American Type Cul-
ture Collection, and the anti-a4 (clone PS/2, rat IgG2b) hybridoma was kindly
provided by David Erle (University of California, San Francisco). Antibodies
were administered intraperitoneally at 100 mg per mouse in PBS. Cells were
treated with 10 ng/ml of oligomer B or PTX at 37C for 10 min, washed twice
in warm RPMI, 2% FCS, and 10 mM HEPES, and then transferred to recipient
mice. For generation of a LYVE-1-specificmAb, DT569 cells (Ba/F3 cells stably
transfected with mouse IL-2 plasmid) were transfected with mouse LYVE-1
inserted into the pEF vector with sequence encoding the preprolactin leader
sequence and Flag epitope inserted in place of the codons for the first 24
amino acids of LYVE-1. Rats were immunized with transfected cells at R&D
Systems, and the resultant hybridoma supernatants were screened for reactiv-
ity to LYVE-1-transfected cells by flow cytometry. Mab 22 stained LYVE-1
transfected cells but not control DT569 cells transfected with Flag-tagged
CCR7. This antibody is now available from R&D systems as clone 223322.
CCR7-specific monoclonal antibody was obtained from BioLegend.
Chemotaxis Assays
Cells were washed in RPMI1640 with 0.5% fatty-acid-free BSA several times,
resensitized for 30 min at 37C, and then tested for transmigration across un-
coated 5 mm transwell filters (Corning Costar) for 3 hr to sphingosine-1-phos-
phate (S1P) (Sigma-Aldrich) or CCL21 (R&D Systems) in the bottom chamber
as described (Reif et al., 2002). FTY720 was from a custom synthesis
performed by SRI International (Menlo Park, CA) and was administered intra-
peritoneally in saline.
Immunohistochemical and Flow Cytometric Analysis
Seven micron cryostat sections were fixed and stained as described (Reif
et al., 2002). CFSE-labeled cells were visualized in sections with alkaline-phos-
phatase-conjugated fluorescein-specific antibodies (Roche). Congenic trans-
ferred lymphocytes were visualized by staining with biotinylated antibodies to
132 Immunity 28, 122–133, January 2008 ª2008 Elsevier Inc.CD45.1 (clone A20) or CD45.2 (Clone 104). For visualization of LYVE-1+ struc-
tures in sections, either unconjugated or biotinylated Mab22 was used. Lym-
phocyte preparations were stained with various fluorochrome-conjugated
antibodies purchased from BD PharMingen or anti-S1P1 as described (Lo
et al., 2005), and data were acquired on an FACS LSRII (Beckton Dickinson)
and analyzed with FlowJo software (Treestar).
Supplemental Data
Three figures are available at http://www.immunity.com/cgi/content/full/28/1/
122/DC1/.
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